Krilogy Financial LLC Cara Therapeutics, Inc. Transaction History

Krilogy Financial LLC

  • $1.35 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$12.45 - $23.47 $8,615 - $16,241
-692 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$17.57 - $23.95 $12,158 - $16,573
692 New
692 $17,000
Q2 2018

Aug 15, 2018
SELL
$11.6 - $19.27 $5,185 - $8,613
-447 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$11.77 - $16.08 $2,354 - $3,215
-200 Reduced 30.91%
447 $6,000
Q2 2017

Aug 15, 2017
BUY
N/A
647
647 $10,000

Others Institutions Holding CARA

# of Institutions
74
Shares Held
12.8M
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $14.5M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Krilogy Financial LLC Portfolio

Follow Krilogy Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krilogy Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email